{"id":2084,"date":"2019-12-05T11:30:32","date_gmt":"2019-12-05T10:30:32","guid":{"rendered":"https:\/\/www.maiwald.eu\/all\/presseberichte\/generics-manufacturers-prevail-over-hogan-lovells-client-msd-juve-patent\/"},"modified":"2021-06-14T19:04:47","modified_gmt":"2021-06-14T17:04:47","slug":"generics-manufacturers-prevail-over-hogan-lovells-client-msd-juve-patent","status":"publish","type":"presseberichte","link":"https:\/\/www.maiwald.eu\/en\/press-coverage\/generics-manufacturers-prevail-over-hogan-lovells-client-msd-juve-patent\/","title":{"rendered":"Generics manufacturers prevail over Hogan Lovells client MSD (JUVE-Patent)"},"content":{"rendered":"\n<p>Various generics manufacturers have won in the second instance in the dispute over supplementary protection certificates for cholesterol-lowering drug Inegy. The Higher Regional Court D\u00fcsseldorf dismissed the appeal of US originator Merck Sharp Dome (MSD) (case IDs: I-2 U 58\/18 &#8211; I-2 U 64\/18 and I-2 U 82\/18). The various pharmaceutical companies may continue to market imitation products in Germany, using the active substance combination ezitimibe and simvastatin.<\/p>\n\n\n\n<p><strong>Representatives<\/strong>:<\/p>\n\n\n\n<p>For MSD (in all cases)<br><strong>Hogan Lovells<\/strong> (D\u00fcsseldorf): Miriam Gundt (lead), Andreas von Falck; associate: Lukas Sievers<br><strong>Abitz &amp; Partner<\/strong> (Munich): Monica Heinemann (patent attorney)<\/p>\n\n\n\n<p>For 1 A Pharma (I-2 U 64\/18), Hexal (I-2 U 58\/18) and Klinge (I-2 U 82\/18)<br><strong>Taylor Wessing<\/strong> (Munich): Jan Rektorschek, Nora Wessendorf, Anja Lunze<br><strong>Maiwald<\/strong> (Munich): <a href=\"https:\/\/www.maiwald.eu\/en\/team\/derk-vos\/\" target=\"_top\" rel=\"noopener\">Derk Vos<\/a> (patent attorney)<\/p>\n\n\n\n<p>For Mylan dura (I-2 U 63\/18)<br><strong>Taylor Wessing<\/strong> (Munich): Christoph de Coster, Verena Bertram<br><strong>Ter Meer Steinmeister &amp; Partner<\/strong> (Munich): Bernd Aechter (patent attorney)<\/p>\n\n\n\n<p>For Ratiopharm (I-2 U 62\/18) and AbZ Pharma (I-2 U 59\/18)<br><strong>Bird &amp; Bird<\/strong> (Hamburg): Anne Wolters-H\u00f6hne (lead); associates: Annika Schneider (D\u00fcsseldorf), Marie-Theres Schmid (patent attorney, Munich)<\/p>\n\n\n\n<p>For Stada (I-2 U 61\/18) and Aliud (I-2 U 60\/18)<br><strong>Bird &amp; Bird<\/strong> (D\u00fcsseldorf): Oliver J\u00fcngst, Moritz Schroeder<br><strong>Hamm &amp; Wittkopp<\/strong> (Hamburg): Alexander Wittkopp (patent attorney)<\/p>\n\n\n\n<p>Higher Regional Court D\u00fcsseldorf, 2nd Civil Senate<br>Thomas K\u00fchnen (presiding judge), Thomas Fricke, Ronny Thomas<\/p>\n\n\n\n<p>The complete Juve-Patent article can be downloaded under:<br><a href=\"https:\/\/www.juve-patent.com\/news-and-stories\/cases\/generics-manufacturers-prevail-over-hogan-lovells-client-msd\/\" target=\"_blank\" rel=\"noopener\">https:\/\/www.juve-patent.com\/news-and-stories\/cases\/generics-manufacturers-prevail-over-hogan-lovells-client-msd\/<\/a><\/p>\n","protected":false},"template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-2084","presseberichte","type-presseberichte","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.maiwald.eu\/en\/wp-json\/wp\/v2\/presseberichte\/2084","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.maiwald.eu\/en\/wp-json\/wp\/v2\/presseberichte"}],"about":[{"href":"https:\/\/www.maiwald.eu\/en\/wp-json\/wp\/v2\/types\/presseberichte"}],"version-history":[{"count":0,"href":"https:\/\/www.maiwald.eu\/en\/wp-json\/wp\/v2\/presseberichte\/2084\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.maiwald.eu\/en\/wp-json\/wp\/v2\/media?parent=2084"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}